Comparison of Therapeutic Efficiency Between Saccharum Iron and Ferrum Dextran Iron: a Multicenter Clinical Trial

XU Bin,JI Da-xi,CHEN Yue-mei,TAO Jing,GONG De-hua,XING Chang-ying,LIU Bi-cheng,CHEN Jiang-hua,ZHANG Ying,ZOU Zuo-jun,ZHAO Xian-guo,WANG Rong,CHEN Wei,JIANG Ai-li,LIU Zhi-hong,LI Lei-shi
DOI: https://doi.org/10.3969/j.issn.1006-298x.2008.02.004
2008-01-01
Abstract:Objective:To compare the efficiency of two kinds of intravenous iron in the patients undergoing maintenance hemodialysis(MHD)in multicenter of blood purification.Methodology:Two hundred and ten patients with stable MHD were collected in ten blood purification centers in whole country.They were randomly divided into two groups:105 patients for saccharum iron treatment as research group and the other for ferrum dextran iron treatment as control group.All patients in the two groups receive 100 mg intravenous iron in twice every week,totally 1 000 mg for the whole treatment.The observing durations of this clinical trial were 8 weeks.During the treatment,the levels of hemoglobin(Hb)、Hhematocrit(Hct)、SF、TSAT were determined every two weeks.The side-effects of drugs were also observed.Results:There were no significant differences between two groups in age,sex,bodyweight,duration of HD,the dosages of EPO,the level of Hb,Hct,SF,and TSAT before the treatment(P0.05).The levels of Hb,Hct,SF,TSAT were increasing obviously in the two groups after four weeks of iron treatment(P0.05).The anemia in those patients was corrected,the dosages of EPO were decreased,and the level of SF,TSAT was increased significantly and maintained.There were no differences between the two groups in above parameters(P0.05).No significant side-effects were found in both research and control group.Conclusion:The intravenous treatment of saccharum iron or ferrum dextran iron for patients with MHD is efficiency and safety.
What problem does this paper attempt to address?